Analyze interleukin-1β, interleukin-6, and tumor necrosis factor-α levels in dry eye and the therapeutic effect of cyclosporine A
Juan Wu,
No information about this author
Guijun Li,
No information about this author
Jie Niu
No information about this author
et al.
World Journal of Clinical Cases,
Journal Year:
2024,
Volume and Issue:
12(25), P. 5665 - 5672
Published: July 12, 2024
Dry
eye
is
a
common
disease.
Artificial
tears
supplements
are
widely
used
for
the
treatment
of
dry
eyes.
However,
multiple
adverse
effects
have
been
observed
in
patients
receiving
long-term
with
artificial
tears,
which
may
affect
therapeutic
effect.
Language: Английский
Multicomponent Dietary Supplementation: Impact on Tear Secretion and Ocular Surface Inflammation in Dry Eye Syndrome Patients
Shih‐Chien Huang,
No information about this author
Yen‐Ping Lei,
No information about this author
Min‐Chien Hsiao
No information about this author
et al.
Antioxidants,
Journal Year:
2025,
Volume and Issue:
14(1), P. 103 - 103
Published: Jan. 16, 2025
Dry
eye
syndrome
(DES)
is
a
prevalent
ocular
condition
characterized
by
tear
film
instability,
inflammation,
and
discomfort,
affecting
millions
worldwide.
DES
related
to
oxidative
stress
imbalance
surface
which
are
important
factors
in
the
development
of
condition.
Recent
studies
have
demonstrated
that
fish
oil,
lutein,
zeaxanthin
possess
anti-inflammatory
antioxidant
properties.
This
study
investigated
efficacy
multicomponent
dietary
supplement
improving
secretion
mitigating
inflammation
patients
with
DES.
It
was
an
open-label
intervention
trial.
In
total,
52
participants
were
randomly
assigned
control
(n
=
23)
(45
mg/day
eicosapentaenoic
acid,
30
docosahexaenoic
1.8
zeaxanthin;
n
29)
groups
for
12
weeks.
The
evaluated
using
Schirmer's
test
disease
index
(OSDI)
as
parameters.
Moreover,
blood
or
stress,
capacities,
inflammatory
indicators
measured
at
weeks
0
12.
results
indicated
significant
increase
reduction
OSDI
scores
group.
Additionally,
markers,
such
interleukin
(IL)-6
IL-8,
significantly
decreased
after
intervention.
However,
group
improved
6.60
points
(β
-6.60,
p
0.01).
These
findings
support
potential
targeted
nutritional
supplementation
safe
effective
strategy
alleviating
symptoms,
offering
alternative
conventional
treatments
exclusively
focus
on
symptom
management.
highlights
role
specific
nutrients
modulating
production
thereby
providing
foundation
approaches
treatment.
Future
research
should
explore
long-term
benefits
interventions
their
impact
overall
health.
Language: Английский
Engineering biocompatible carbon dots nano-enzymes hydrogel for efficient antioxidative and anti-inflammatory treatment of dry eye disease
Journal of Controlled Release,
Journal Year:
2025,
Volume and Issue:
381, P. 113490 - 113490
Published: March 10, 2025
Language: Английский
Advances in the application of smart materials in the treatment of ophthalmic diseases
Yida Liu,
No information about this author
Hong Ren,
No information about this author
Zhenkai Wu
No information about this author
et al.
Biomaterials,
Journal Year:
2025,
Volume and Issue:
unknown, P. 123316 - 123316
Published: April 1, 2025
Language: Английский
Aminated Fullerene for Comprehensive Dry Eye Therapy: Promoting Epithelial-Barrier Reconstruction and Nerve Regeneration by Suppressing Oxidation and Inflammation
Ying Lyu,
No information about this author
Qichuan Yin,
No information about this author
Xiaodan Liao
No information about this author
et al.
Biomaterials,
Journal Year:
2025,
Volume and Issue:
unknown, P. 123329 - 123329
Published: April 1, 2025
Language: Английский
Dry Eye Disease: Oxidative Stress on Ocular Surface and Cutting‐Edge Antioxidants
Global Challenges,
Journal Year:
2025,
Volume and Issue:
unknown
Published: May 14, 2025
Abstract
Dry
eye
disease
(DED),
a
multifactorial
ocular
surface
disorder
characterized
by
tear
film
instability,
is
pathologically
linked
to
oxidative
damage.
The
accumulation
of
reactive
oxygen
species
(ROS)
across
tissues
not
only
directly
damages
nucleic
acids,
proteins,
and
lipids,
but
also
functions
as
an
upstream
driver
inflammation
hyperosmolarity,
collectively
disrupting
cellular
homeostasis.
This
review
comprehensively
delineates
the
mechanistic
interplay
between
stress
(OS)
DED
pathogenesis,
synthesizing
evidence
on
enzymatic/
nonenzymatic
antioxidant
alterations
in
samples
corneal,
lacrimal,
conjunctival,
meibomian
gland,
tissues,
alongside
quantitative
profiling
OS
biomarkers,
such
4‐hydroxynonenal
(4HNE),
malondialdehyde
(MDA),
8‐hydroxy‐2′‐deoxyguanosine
(8‐OHdG),
3‐nitrotyrosine
(3‐NT).
Furthermore,
therapeutic
mechanisms
clinically
approved
investigational
antioxidants,
including
SKQ1,
rebamipide,
mitoquinone,
elamipretide,
lactoferrin,
nanozymes,
graphene
quantum
dots,
tetrahedral
frame
Chinese
medicine
monomers
are
critically
evaluated.
With
changes
modern
social
environment
lifestyle,
influence
gradually
expanding.
Antioxidant‐based
interventions
poised
become
cornerstone
components
multimodal
management
strategies.
Language: Английский
Revolutionizing Retinal Therapy: The Role of Nanoparticle Drug Carriers in Managing Vascular Retinal Disorders
Huihui Lu,
No information about this author
Na He,
No information about this author
Lina Zhang
No information about this author
et al.
Clinical ophthalmology,
Journal Year:
2025,
Volume and Issue:
Volume 19, P. 1565 - 1582
Published: May 1, 2025
Vascular
Retinopathy
(VR),
such
as
diabetic
retinopathy,
pose
significant
challenges
to
vision
and
overall
health.
Traditional
treatment
methods
often
face
limitations
in
efficacy
delivery.
retinopathy
is
a
common
potentially
blinding
group
of
eye
diseases
with
core
pathologic
mechanisms
involving
vascular
injury,
ischemia,
exudation,
neovascularization.
Clinical
management
relies
heavily
on
etiologic
control
(eg,
diabetes,
hypertension),
anti-VEGF
therapy,
laser
surgical
intervention.
Recent
advancements
nanotechnology
have
led
the
development
innovative
nanoparticle
drug
carriers,
which
offer
promising
solutions
for
targeted
sustained
delivery
retinal
environment.
This
review
explores
application
both
conventional
novel
carriers
treating
VR.
We
discuss
various
types
nanoparticles,
including
liposomes,
polymeric
metal-based
highlighting
their
unique
properties,
action,
therapeutic
benefits.
Finally,
we
provide
insights
into
future
perspectives
nanoparticle-based
therapies
disorders,
emphasizing
potential
improved
patient
outcomes
need
further
research
optimize
these
advanced
systems.
Language: Английский
Dual-Stabilized Selenium Nanoparticles with Chitosan and SS31 Peptide: Resolving instability for enhancing ROS elimination, suppressing inflammation, and combating bacterial infections
Panpan Ming,
No information about this author
Yuwen Wei,
No information about this author
Yawen Zhu
No information about this author
et al.
Colloids and Surfaces B Biointerfaces,
Journal Year:
2025,
Volume and Issue:
253, P. 114749 - 114749
Published: May 1, 2025
Language: Английский
Corneal Mucin‐Targeting Liposome Nanoplatforms Enable Effective Treatment of Dry Eye Diseases by Integrated Regulation of Ferroptosis and Inflammation
Yin Zhang,
No information about this author
Tinglian Zhou,
No information about this author
Kai Wang
No information about this author
et al.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 28, 2024
Abstract
The
incidence
of
dry
eye
disease
(DED)
has
been
increasing
annually
worldwide,
creating
an
urgent
need
for
new
therapies.
Due
to
the
multifactorial
mechanism
underlying
DED,
traditional
medications
focused
on
decreasing
ocular
surface
inflammation
have
unable
address
all
harmful
factors
and
fail
achieve
a
complete
clinical
cure.
Ferroptosis,
form
programmed
cell
death
characterized
by
lipid
peroxidation,
become
pivotal
contributor
oxidative
stress‐driven
pathology.
Therefore,
therapeutic
targeting
ferroptosis
may
be
attractive
option
management.
Herein,
sialic
acid‐targeting
peptide‐modified
liposome
loaded
with
Cyclosporine
A
(CsA),
typical
anti‐inflammatory
drug,
Ferrostatin‐1
(Fer‐1),
selective
inhibitor,
is
developed
termed
as
CF@SNPs,
combing
sustaining
DED
treatment.
This
multifunctional
liposomal
encapsulation
demonstrates
excellent
aqueous
solubility;
moreover,
peptide
prolongs
retention,
further
enhancing
efficacy.
CF@SNPs
treatment
comprehensively
alleviates
symptoms,
including
improving
corneal
defects,
augmenting
goblet
count,
restoring
tear
secretion.
Specifically,
attenuate
pathology
suppressing
p53‐SLC7A11‐GSH‐dependent
TNF‐α‐associated
inflammatory
cascades,
accompanied
favorable
biocompatibility
in
vivo.
These
results
underscore
promising
potential
this
superior
nano‐formulation
pharmacotherapy.
Language: Английский
Global research hotspots and trends in anti-inflammatory studies in dry eye: a bibliometric analysis (2004–2024)
Frontiers in Medicine,
Journal Year:
2024,
Volume and Issue:
11
Published: Nov. 28, 2024
Inflammation
plays
a
crucial
role
in
the
pathophysiology
of
dry
eye
(DE).
This
study
aims
to
provide
comprehensive
overview
current
status,
hotspots
and
trends
DE
anti-inflammatory
research
through
bibliometric
analysis.
Language: Английский